Zobrazeno 1 - 9
of 9
pro vyhledávání: '"I. A. Dain"'
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 3, Pp 84-89 (2022)
Introduction. The low solubility of active pharmaceutical ingredients (APIs) in the physiological pH range of the intestinal tract can adversely affect their absorption and bioavailability. Various methods of increasing the solubility of APIs have be
Externí odkaz:
https://doaj.org/article/a5b958ab2e7545709a97d65538905197
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 11, Iss 2, Pp 87-93 (2022)
Introduction. Many of new active pharmaceutical ingredients (APIs) have low solubility that can affect bioavailability negatively and therefore therapeutically efficacy as well. These APIs include the following antiretroviral substances: ritonavir, e
Externí odkaz:
https://doaj.org/article/329d331b33f345efa62c97a06ab8a58d
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 4, Pp 28-35 (2021)
Introduction. Etravirine, being one of the most popular antiretroviral drugs, doesn't have its physicochemical properties sufficiently described in scientific publications. Detailed information on the substance properties is necessary both for organi
Externí odkaz:
https://doaj.org/article/6683c065752944b4a33e3410217a2a3a
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 67-73 (2021)
Introduction. Usage of aggressive conditions (solvents, high temperature, etc.) in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance. Darunavir (D) amorphous and darunavir ethanolate (DE) crystalline bot
Externí odkaz:
https://doaj.org/article/fd3f60cf041542e9964980364c6b9841
Publikováno v:
Pharmaceutical Chemistry Journal. 56:1290-1296
Publikováno v:
Pharmaceutical Chemistry Journal.
Publikováno v:
Разработка и регистрация лекарственных средств, Vol 10, Iss 1, Pp 67-73 (2021)
Introduction. Usage of aggressive conditions (solvents, high temperature, etc.) in a dosage form manufacturing can lead to a change in the properties of a pharmaceutical substance. Darunavir (D) amorphous and darunavir ethanolate (DE) crystalline bot
Publikováno v:
Vestnik Voronežskogo Gosudarstvennogo Universiteta Inženernyh Tehnologij, Vol 79, Iss 4, Pp 165-174 (2018)
To develop boron deficiency treatment composite preparations for significant agricultural crops tris(2-hydroxyethyl)ammonium complexes containing boron and lower dicarboxylic acid (C2-C4) anions were synthesized and characterized. It was shown, that
Autor:
P. A. Storozhenko, I. A. Dain, Victor B. Rybakov, D. A. Gordeev, S. V. Loginov, E. N. Ofitserov
Publikováno v:
Crystallography Reports. 63:58-64
Succinic acid salts-tris(2-hydroxyethyl)ammonium succinate (C6H16NO3) 2 + C4H4O 4 2− (monoclinic crystals, sp. gr. P21/c, Z = 4) and tris(2-hydroxyethyl)ammonium hydrogen succinate (C6H16NO3)+C4H5O 4 − (monoclinic crystals, sp. gr. P21/c, Z = 4)